19739-41-4 Usage
Uses
Used in Pharmaceutical Industry:
(6-NITRO-2-OXO-1,3-BENZOXAZOL-3(2H)-YL)ACETIC ACID is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows it to be a promising candidate in drug development, potentially leading to the creation of new medications with novel mechanisms of action.
Used in Agricultural Industry:
In agriculture, (6-NITRO-2-OXO-1,3-BENZOXAZOL-3(2H)-YL)ACETIC ACID may be utilized as a component in the development of agrochemicals, such as pesticides or herbicides. Its specific properties could contribute to the creation of more effective and environmentally friendly products for crop protection.
Used in Materials Science:
(6-NITRO-2-OXO-1,3-BENZOXAZOL-3(2H)-YL)ACETIC ACID has potential applications in materials science, where it could be employed in the development of new materials with unique properties. Its incorporation into polymers or other materials may lead to advancements in areas such as electronics, coatings, or composites.
Note: The specific applications and benefits of (6-NITRO-2-OXO-1,3-BENZOXAZOL-3(2H)-YL)ACETIC ACID in these industries are not explicitly mentioned in the provided materials. The potential uses listed above are speculative and would require further research and testing to confirm.
Check Digit Verification of cas no
The CAS Registry Mumber 19739-41-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,7,3 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 19739-41:
(7*1)+(6*9)+(5*7)+(4*3)+(3*9)+(2*4)+(1*1)=144
144 % 10 = 4
So 19739-41-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H6N2O6/c12-8(13)4-10-6-2-1-5(11(15)16)3-7(6)17-9(10)14/h1-3H,4H2,(H,12,13)
19739-41-4Relevant academic research and scientific papers
Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA
Pedgaonkar, Ganesh S.,Sridevi, Jonnalagadda Padma,Jeankumar, Variam Ullas,Saxena, Shalini,Devi, Parthiban Brindha,Renuka, Janupally,Yogeeswari, Perumal,Sriram, Dharmarajan
, p. 6134 - 6145 (2015/02/19)
A series of twenty seven substituted 2-(2-oxobenzo[d]oxazol-3(2H)-yl)acetamide derivatives were designed based on our earlier reported Mycobacterium tuberculosis (MTB) enoyl-acyl carrier protein reductase (InhA) lead. Compounds were evaluated for MTB InhA inhibition study, in vitro activity against drug-sensitive and -resistant MTB strains, and cytotoxicity against RAW 264.7 cell line. Among the compounds tested, 2-(6-nitro-2-oxobenzo[d]oxazol-3(2H)-yl)-N-(5-nitrothiazol-2-yl)acetamide (30) was found to be the most promising compound with IC50 of 5.12 ± 0.44 μM against MTB InhA, inhibited drug sensitive MTB with MIC 17.11 μM and was non-cytotoxic at 100 μM. The interaction with protein and enhancement of protein stability in complex with compound 30 was further confirmed biophysically by differential scanning fluorimetry.
